Silencing of HIV-1 by AgoshRNA molecules
Silencing of HIV-1 by AgoshRNA molecules …………… Herrera-Carrillo E, Harwig A, Berkhout B. Gene Ther. 2017 May 29. PubMed 00
Silencing of BCR/ABL Chimeric Gene in Human Chronic Myelogenous Leukemia Cell Line K562 by siRNA-Nuclear Export Signal Peptide Conjugates
Silencing of BCR/ABL Chimeric Gene in Human Chronic Myelogenous Leukemia Cell Line K562 by siRNA-Nuclear Export Signal Peptide Conjugates …………… Shinkai Y, Kashihara S, Minematsu G, Fujii H, Naemura M, Kotake Y, Morita Y, Ohnuki K, Fokina AA, Stetsenko DA, Filichev VV, Fujii M. Nucleic Acid Ther. 2017 Jun;27(3):168-175. PubMed 00
Altered expression and modulation of the two-pore domain (K2p) mechano-gated potassium channel TREK-1 in overactive human detrusor
Altered expression and modulation of the two-pore domain (K2p) mechano-gated potassium channel TREK-1 in overactive human detrusor …………… Pineda RH, Nedumaran B, Hypolite JA, Pan XQ, Wilson S, Meacham RB, Malykhina AP. Am J Physiol Renal Physiol. 2017 May 24 PubMed 00
Targeting long non-coding RNA ASBEL with oligonucleotide antagonist for breast cancer therapy
Targeting long non-coding RNA ASBEL with oligonucleotide antagonist for breast cancer therapy …………… Xia Y, Xiao X, Deng X, Zhang F, Zhang X, Hu Q, Sheng W. Biochem Biophys Res Commun. 2017 May 25. PubMed 00